Joffre Baker

16.7k total citations · 2 hit papers
68 papers, 12.1k citations indexed

About

Joffre Baker is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Joffre Baker has authored 68 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cancer Research, 28 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Joffre Baker's work include Protease and Inhibitor Mechanisms (19 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Molecular Biology Techniques and Applications (14 papers). Joffre Baker is often cited by papers focused on Protease and Inhibitor Mechanisms (19 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Molecular Biology Techniques and Applications (14 papers). Joffre Baker collaborates with scholars based in United States and United Kingdom. Joffre Baker's co-authors include Steven Shak, Maureen Cronin, Drew Watson, Norman Wolmark, Soonmyung Paik, Frederick L. Baehner, Chungyeul Kim, John Bryant, Gong Tang and D. Lawrence Wickerham and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Joffre Baker

68 papers receiving 11.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

2004 4.5k citations Soonmyung Paik, Steven Shak et al. New England Journal of Medicine profile →
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

2006 1.9k citations Soonmyung Paik, Gong Tang et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joffre Baker United States	38	7.3k	5.0k	4.5k	1.8k	1.6k	68	12.1k
F. Jänicke Germany	54	6.2k 0.9×	5.5k 1.1×	3.1k 0.7×	1.3k 0.7×	715 0.4×	183	11.3k
Nils Brünner Denmark	56	5.0k 0.7×	4.1k 0.8×	4.0k 0.9×	1000 0.5×	597 0.4×	238	9.9k
Francesco Pezzella United Kingdom	58	4.5k 0.6×	4.1k 0.8×	7.0k 1.6×	600 0.3×	1.5k 0.9×	159	12.1k
Åke Borg Sweden	75	6.8k 0.9×	6.9k 1.4×	10.3k 2.3×	5.1k 2.8×	2.1k 1.3×	275	18.7k
Maria Grazia Daidone Italy	59	5.6k 0.8×	6.2k 1.2×	8.0k 1.8×	1.2k 0.7×	1.3k 0.8×	279	14.6k
Dionyssios Katsaros Italy	61	4.5k 0.6×	4.6k 0.9×	7.1k 1.6×	874 0.5×	860 0.5×	200	13.7k
Boris Reva United States	22	5.0k 0.7×	4.7k 0.9×	11.3k 2.5×	1.5k 0.8×	1.5k 0.9×	50	16.9k
Maxime P. Look Netherlands	49	4.5k 0.6×	3.6k 0.7×	5.9k 1.3×	1.2k 0.7×	526 0.3×	115	10.0k
Celina G. Kleer United States	65	5.8k 0.8×	7.9k 1.6×	9.2k 2.0×	1.3k 0.7×	2.0k 1.3×	174	17.2k
Gert Auer Sweden	58	3.9k 0.5×	3.8k 0.8×	4.9k 1.1×	1.6k 0.9×	2.2k 1.4×	373	11.7k

Countries citing papers authored by Joffre Baker

Since Specialization

Citations

This map shows the geographic impact of Joffre Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joffre Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joffre Baker more than expected).

Fields of papers citing papers by Joffre Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joffre Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joffre Baker. The network helps show where Joffre Baker may publish in the future.

Co-authorship network of co-authors of Joffre Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Joffre Baker. A scholar is included among the top collaborators of Joffre Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joffre Baker. Joffre Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kwei, Kevin, Joffre Baker, & Robert J. Pelham. (2012). Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line Collection. PLoS ONE. 7(9). e46518–e46518. 40 indexed citations

Sinicropi, Dominick, Kunbin Qu, François Collin, et al.. (2012). Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue. PLoS ONE. 7(7). e40092–e40092. 59 indexed citations

Baker, Joffre, Debjani Dutta, Drew Watson, et al.. (2011). Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer. British Journal of Cancer. 104(3). 488–495. 81 indexed citations

O’Connell, Michael J., Ian C. Lavery, Greg Yothers, et al.. (2010). Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin. Journal of Clinical Oncology. 28(25). 3937–3944. 220 indexed citations

Morlan, John, Joffre Baker, & Dominick Sinicropi. (2009). Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method. PLoS ONE. 4(2). e4584–e4584. 84 indexed citations

Clark-Langone, Kim M., Jenny Wu, Chithra Sangli, et al.. (2007). Biomarker discovery for colon cancer using a 761 gene RT-PCR assay. BMC Genomics. 8(1). 279–279. 42 indexed citations

Chang, Jenny C., Andreas Makris, Maya Gutierrez, et al.. (2007). Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients. Breast Cancer Research and Treatment. 108(2). 233–240. 107 indexed citations

Kiefer, Michael, Kenneth Hoyt, James Hackett, Michael G. Walker, & Joffre Baker. (2006). Multiple GSTM gene family members are recurrence risk markers in breast cancer. Cancer Research. 66. 846–846. 1 indexed citations

Mina, Lida A., Sunil Badve, Joffre Baker, et al.. (2006). Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue. Breast Cancer Research and Treatment. 103(2). 197–208. 80 indexed citations

10.

Paik, Soonmyung, Gong Tang, Steven Shak, et al.. (2006). Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer. Journal of Clinical Oncology. 24(23). 3726–3734. 1871 indexed citations breakdown →

11.

Esteva, Francisco J., Ayşegül A. Şahin, Massimo Cristofanilli, et al.. (2005). Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy. Clinical Cancer Research. 11(9). 3315–3319. 132 indexed citations

12.

Cobleigh, Melody, Pincas Bitterman, Joffre Baker, et al.. (2005). Tumor Gene Expression and Prognosis in Breast Cancer Patients with 10 or More Positive Lymph Nodes. Clinical Cancer Research. 11(24). 8623–8631. 159 indexed citations

13.

Paik, Soonmyung, Steven Shak, Ge Tang, et al.. (2005). Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer. Journal of Clinical Oncology. 23(16_suppl). 510–510. 73 indexed citations

14.

Paik, Soonmyung, Steven Shak, Gong Tang, et al.. (2004). A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer. New England Journal of Medicine. 351(27). 2817–2826. 4451 indexed citations breakdown →

15.

Cronin, Maureen, Mylan Pho, Debjani Dutta, et al.. (2004). Measurement of Gene Expression in Archival Paraffin-Embedded Tissues. American Journal Of Pathology. 164(1). 35–42. 426 indexed citations

16.

Rao, Jia‐Sheng, et al.. (1989). Protease nexin I, a serpin, inhibits plasminogen‐dependent degradation of muscle extracellular matrix. Muscle & Nerve. 12(8). 640–646. 24 indexed citations

17.

Laug, Walter E., et al.. (1989). Isolation of Multiple Types of Plasminogen Activator Inhibitors from Vascular Smooth Muscle Cells. Thrombosis and Haemostasis. 61(3). 517–521. 21 indexed citations

18.

Gronke, Robert S., Barbara Bergman, & Joffre Baker. (1987). Thrombin interaction with platelets. Influence of a platelet protease nexin.. Journal of Biological Chemistry. 262(7). 3030–3036. 50 indexed citations

19.

Bajpai, Anil & Joffre Baker. (1985). Cryptic urokinase binding sites on human foreskin fibroblasts. Biochemical and Biophysical Research Communications. 133(2). 475–482. 60 indexed citations

20.

Low, David A., Randy W. Scott, Joffre Baker, & Dennis D. Cunningham. (1982). Cells regulate their mitogenic response to thrombin through release of protease nexin. Nature. 298(5873). 476–478. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact